Outcome of allogeneic haematopoetic stem cell transplantation for patients with primary or secondary resistance to imatinib in chronic myeloid leukaemia

被引:0
作者
Koldehoff, M [1 ]
Elmaagacli, AH [1 ]
Steckel, NK [1 ]
Hlinka, M [1 ]
Ditschkowski, M [1 ]
Trenschel, R [1 ]
Peceny, R [1 ]
Beelen, DW [1 ]
机构
[1] Univ Hosp, Essen, Germany
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S236 / S236
页数:1
相关论文
共 50 条
[41]   Allogeneic bone marrow transplantation versus imatinib mesilate for patients with chronic myeloid leukaemia in first chronic phase [J].
Bittencourt, H. ;
Funke, V. ;
Fogliatto, L. ;
Magalhaes, S. ;
Setubal, D. ;
Paz, A. ;
Macedo, A. ;
Ruiz, J. ;
Azambuja, A. ;
Silla, L. ;
Clementino, N. ;
Pasquini, R. .
BONE MARROW TRANSPLANTATION, 2008, 41 :S305-S305
[42]   Imatinib for relapsed Philadelphia chromosome positive chronic myeloid leukaemia after allogeneic haematopoeitic cell transplantation [J].
Daneschnejad, S ;
Lange, T ;
Mueller, C ;
Musiol, S ;
Niederwieser, D .
BONE MARROW TRANSPLANTATION, 2005, 35 :S234-S235
[43]   Impact of imatinib therapy on the use of allogeneic haematopoietic progenitor cell transplantation for the treatment of chronic myeloid leukaemia [J].
Giralt, Sergio A. ;
Arora, Mukta ;
Goldman, John M. ;
Lee, Stephanie J. ;
Maziarz, Richard T. ;
McCarthy, Philip L. ;
Sobocinski, Kathleen A. ;
Horowitz, Mary M. .
BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 (05) :461-467
[44]   Allogeneic Stem Cell Transplantation in Refractory Acute Myeloid Leukaemia [J].
Bono, Roberto ;
Sapienza, Giuseppe ;
Tringali, Stefania ;
Rotolo, Cristina ;
Patti, Caterina ;
Mule, Antonino ;
Calafiore, Valeria ;
Santoro, Alessandra ;
Castagna, Luca .
CELLS, 2024, 13 (09)
[45]   5-Azacytidine (Aza) in Acute Myeloid Leukaemia (AML) relapse after Allogeneic Haematopoetic Stem Cell Transplantation (HSCT) [J].
Deligiannis, I ;
Gueluec, S. ;
Boruga, C. ;
Heil, G. .
ONKOLOGIE, 2013, 36 :51-51
[46]   Results of stem cell transplantation in paediatric patients with chronic myeloid leukaemia [J].
Suttorp, M ;
Claviez, A ;
Martiniak, Y .
BONE MARROW TRANSPLANTATION, 2005, 35 :S20-S20
[47]   Durability of molecular remission in chronic myeloid leukemia patients treated with imatinib vs allogeneic stem cell transplantation [J].
Lange, T ;
Bumm, T ;
Mueller, M ;
Otto, S ;
Al-Ali, HK ;
Grommisch, L ;
Musiol, S ;
Franke, C ;
Krahl, R ;
Niederwieser, D ;
Deininger, M .
LEUKEMIA, 2005, 19 (07) :1262-1265
[48]   Durability of molecular remission in chronic myeloid leukemia patients treated with imatinib vs allogeneic stem cell transplantation [J].
T Lange ;
T Bumm ;
M Mueller ;
S Otto ;
H-K Al-Ali ;
L Grommisch ;
S Musiol ;
C Franke ;
R Krahl ;
D Niederwieser ;
M W N Deininger .
Leukemia, 2005, 19 :1262-1265
[49]   Outcomes of allogeneic stem cell transplantation for secondary therapy-related acute myeloid leukaemia [J].
Cudillo, L. I. ;
Ceresoli, E. ;
Di Veroli, A. ;
Cerretti, R. ;
Mariotti, B. ;
Provenzano, I. ;
Picardi, A. ;
De Angelis, G. ;
Giannotti, F. ;
Vaccarini, S. ;
Buccisano, F. ;
Petti, C. ;
Panetta, P. ;
Arcese, W. .
BONE MARROW TRANSPLANTATION, 2012, 47 :S96-S97
[50]   Donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukaemia [J].
Gilleece, MH ;
Dazzi, F .
LEUKEMIA & LYMPHOMA, 2003, 44 (01) :23-28